Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 71

Similar articles for PubMed (Select 22240542)

1.

Vaccination of oncology patients: an effective tool and an opportunity not to be missed.

Kotton CN, Poznansky MC.

Oncologist. 2012;17(1):1-2. doi: 10.1634/theoncologist.2011-0383. Epub 2012 Jan 12. No abstract available.

2.

Pandemic (H1N1) 2009 vaccine in paediatric oncology patients: one dose or two doses?

Cheng FW, Chan PK, Leung WK, Lee V, Shing MK, Yeung AC, Li CK.

Br J Haematol. 2011 Aug;154(3):408-9. doi: 10.1111/j.1365-2141.2010.08501.x. Epub 2011 Apr 13. No abstract available.

PMID:
21488856
3.

Immunogenicity of pandemic (H1N1) 2009 vaccine in children with cancer in the United Kingdom.

Bate J, Yung CF, Hoschler K, Sheasby L, Morden J, Taj M, Heath PT, Miller E.

Clin Infect Dis. 2010 Dec 15;51(12):e95-104. doi: 10.1086/657403. Epub 2010 Nov 10.

4.

Attitudes toward vaccination for pandemic H1N1 and seasonal influenza in patients with hematologic malignancies.

Chin-Yee BH, Monkman K, Hussain Z, Minuk LA.

J Support Oncol. 2011 Jul-Aug;9(4):156-60.

PMID:
21809521
5.

Immune response to 2009 pandemic H1N1 influenza virus A monovalent vaccine in children with cancer.

Yen TY, Jou ST, Yang YL, Chang HH, Lu MY, Lin DT, Lin KH, Huang LM, Chang LY.

Pediatr Blood Cancer. 2011 Dec 15;57(7):1154-8. doi: 10.1002/pbc.23113. Epub 2011 Mar 21.

PMID:
21425448
6.

Positive attitudes of French general practitioners towards A/H1N1 influenza-pandemic vaccination: a missed opportunity to increase vaccination uptakes in the general public?

Schwarzinger M, Verger P, Guerville MA, Aubry C, Rolland S, Obadia Y, Moatti JP.

Vaccine. 2010 Mar 24;28(15):2743-8. doi: 10.1016/j.vaccine.2010.01.027. Epub 2010 Jan 29.

PMID:
20117271
7.

A/H1N1 influenza vaccination in patients with systemic lupus erythematosus: safety and immunity.

Lu CC, Wang YC, Lai JH, Lee TS, Lin HT, Chang DM.

Vaccine. 2011 Jan 10;29(3):444-50. doi: 10.1016/j.vaccine.2010.10.081. Epub 2010 Nov 13.

PMID:
21078406
8.

Adverse events associated with the 2009 H1N1 influenza vaccination and the vaccination coverage rate in health care workers.

Park SW, Lee JH, Kim ES, Kwak YG, Moon CS, Yeom JS, Lee JH, Lee CS.

Am J Infect Control. 2011 Feb;39(1):69-71. doi: 10.1016/j.ajic.2010.08.007. Epub 2010 Dec 3.

PMID:
21122948
9.

Successful H1N1 influenza vaccination of children receiving chemotherapy for solid tumors.

Shahin K, Lina B, Billaud G, Pedone C, Faure-Conter C.

J Pediatr Hematol Oncol. 2012 Aug;34(6):e228-31. doi: 10.1097/MPH.0b013e318241f7d9.

PMID:
22810755
10.

Seasonal influenza vaccination and the 2009 pandemic.

Mercer G, Kelly H.

Clin Infect Dis. 2011 Mar 15;52(6):828-9; author reply 830-1. doi: 10.1093/cid/cir035. No abstract available.

11.

Utility of influenza vaccination for oncology patients.

Pollyea DA, Brown JM, Horning SJ.

J Clin Oncol. 2010 May 10;28(14):2481-90. doi: 10.1200/JCO.2009.26.6908. Epub 2010 Apr 12. Review.

PMID:
20385981
12.

2009 seasonal and H1N1 influenza vaccination compliance in asthmatic children and adults.

Leo HL, Clark SJ, Butchart AT, Singer DC, Clark NM, Davis MM.

J Allergy Clin Immunol. 2010 Jul;126(1):166-8. doi: 10.1016/j.jaci.2010.03.040. Epub 2010 May 23. No abstract available.

PMID:
20546882
13.

2009 novel H1N1 influenza: the impact of viral genomic reassortment on immune evasion and vaccine strategy.

Huang YH.

J Chin Med Assoc. 2009 Jun;72(6):281-2. doi: 10.1016/S1726-4901(09)70372-7. No abstract available.

PMID:
19541561
14.

Narcolepsy after A/H1N1 vaccination.

Mendes MF, Valladares Neto Dde C, Azevedo RA, Caramelli P.

Clinics (Sao Paulo). 2012;67(1):77-8. No abstract available. Erratum in: Clinics (Sao Paulo). 2012;67(5):541.

15.

Lessons learnt from pandemic A(H1N1) 2009 influenza vaccination. Highlights of a European workshop in Brussels (22 March 2010).

Hanquet G, Van Damme P, Brasseur D, De Cuyper X, Gregor S, Holmberg M, Martin R, Molnár Z, Pompa MG, Snacken R, van der Sande M, Van Ranst M, Wirtz A, Neels P.

Vaccine. 2011 Jan 10;29(3):370-7. doi: 10.1016/j.vaccine.2010.10.079. Epub 2010 Nov 12.

PMID:
21075164
16.

Pandemic whole-virion, Vero-cell-derived, adjuvant-free influenza A H1N1 vaccine in patients with solid tumors and hematologic malignancies receiving concurrent anticancer treatment: Immunogenicity, tolerability, and acceptability during the pandemic situation.

Lagler H, Tobudic S, Ramharter M, Elandt K, Sperr WR, Redlberger-Fritz M, Popow-Kraupp T, Jäger U, Zielinski CC, Burgmann H.

Vaccine. 2012 Nov 6;30(48):6864-70. doi: 10.1016/j.vaccine.2012.09.005. Epub 2012 Sep 16.

PMID:
22989690
17.

Introducing vaccine against H1N1 influenza virus in schools.

Enquselassie F.

Ethiop Med J. 2010 Oct;48(4):2p preceding 257. No abstract available.

PMID:
21280426
18.

Serological response to influenza A H1N1 vaccine (Pandemrix®) and seasonal influenza vaccine 2009/2010 in renal transplant recipients and in hemodialysis patients.

Ott U, Sauerbrei A, Lange J, Schäfler A, Walther M, Wolf G, Wutzler P, Zell R, Krumbholz A.

Med Microbiol Immunol. 2012 Aug;201(3):297-302. doi: 10.1007/s00430-012-0231-8. Epub 2012 Feb 17.

PMID:
22350187
19.

[Immunogenicity for different formulation of influenza A (H1N1) 2009 vaccines: a meta-analysis of seven randomized clinical trials].

He HQ, Chen EF, Li Q, Zhao YR, Fu J.

Zhonghua Liu Xing Bing Xue Za Zhi. 2010 May;31(5):590-2. Chinese. No abstract available.

PMID:
22993766
20.

Low level of seroconversion after a novel influenza A/H1N1/2009 vaccination in Japanese patients with rheumatoid arthritis in the 2009 season.

Iwamoto M, Homma S, Onishi S, Kamata Y, Nagatani K, Yamagata Z, Minota S.

Rheumatol Int. 2012 Nov;32(11):3691-4. doi: 10.1007/s00296-011-2118-1. Epub 2011 Sep 1.

PMID:
21881985
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk